Description
Pi™, Prostate Intelligence™, is an AI and machine learning
based software system designed to help radiologists detect and report the
presence of prostate cancer lesions from MR scans (MRI).
We designed Pi to augment a radiologist’s interpretation of
prostate MRI in three ways:
- Improve
patient selection/prioritisation for biopsy
This is achieved by outputting a risk score aiming for both
high negative predictive value (NPV) and specificity. Depending on clinical
priorities, this could be used to reduce unnecessary biopsies and overdiagnosis
of insignificant cancers, streamline workflow or waiting lists, or help reduce
radiologists workload
- Improve
identification of targets for biopsy
This involves identifying candidate regions of interest with
high NPV, to help ensure that all areas of suspicion are targeted for biopsy
and help reduce underdiagnosis (missed clinically significant cancers)
- Provide
high quality segmentations
Outputting machine generated segmentations that compare well
to human expert annotations, to support visualisation, analysis and biopsy
targeting
Please note that Pi does not make a direct diagnosis and is
only available in selected countries. Contact Lucida Medical for further
details. The software is not for sale in the US.
